Randomized Controlled Trial
Copyright ©2014 Baishideng Publishing Group Inc.
World J Diabetes. Dec 15, 2014; 5(6): 962-968
Published online Dec 15, 2014. doi: 10.4239/wjd.v5.i6.962
Table 3 Dietary intake of study participants at baseline and throughout the study1
Run-in period
Throughout the study
FDS supplementPlaceboP2FDS supplementPlaceboP2
n = 19n = 17n = 19n = 17
Energy in kcal/d1760.36 ± 145.211697.04 ± 132.420.691784.03 ± 162.321624.42 ± 158.020.47
Fat in g/d75.04 ± 5.1769.88 ± 7.620.9668.41 ± 4.6873.21 ± 3.080.34
SFA in g/d22.36 ± 1.6521.62 ± 1.820.7221.98 ± 1.6021.23 ± 1.440.48
PUFA in g/d19.39 ± 1.9216.14 ± 1.510.02319.79 ± 1.7418.5 ± 1.810.46
MUFA in g/d20.68 ± 1.7021.32 ± 1.260.4122.56 ± 1.5121.98 ± 1.420.65
Cholesterol in mg/d173.12 ± 14.23158 ± 12.160.46169.54 ± 12.50160.02 ± 14.140.94
Dietary fiber in g/d15.68 ± 1.2014.73 ± 1.600.2814.25 ± 1.8314.21 ± 1.400.56
Vitamin E in mg/d3.65 ± 1.724.51 ± 1.270.354.79 ± 1.504.15 ± 1.420.65
Vitamin C in mg/d71.25 ± 25.0268.42 ± 18.120.7564.54 ± 16.3269.47 ± 21.560.48
Zinc in mg/d8.24 ± 1.329.80 ± 1.420.437.53 ± 1.258.67 ± 1.360.09